Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Giuseppina Borutti"'
Autor:
Elisa Candeloro, Marco Mauri, Maria Vittoria Calloni, MariaLuisa Delodovici, Lucia Tancredi, Bruno Censori, Franca Mazzucchelli, Giuseppina Borutti, Maria Sessa, Elena Ballabio, Chiara Scaccabarozzi, Megi Meneri, Elisabetta Forapani, Claudio De Piazza, Laura Fusi, Marco Gallazzi, Ignazio Santilli, Massimiliano Braga
Publikováno v:
J. of Health Science. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db407f559bc6ee167db383c02a5a4f6f
https://doi.org/10.17265/2328-7136/2019.04.007
https://doi.org/10.17265/2328-7136/2019.04.007
Autor:
Carla Arbasino, Claudia Camana, Giovanni Piccolo, Diego Franciotta, Giuseppina Borutti, Giada Gola, Maria Grazia Egitto, Carlo Dallocchio
Publikováno v:
Functional Neurology.
Posterior reversible encephalopathy syndrome (PRES) is a rare occurrence in patients with Guillain-Barre syndrome (GBS). Two patients with neuroradiological evidence of PRES without central nervous system (CNS) symptoms were recently reported. We pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e39d15e4d4718b9c1efb4c2ac14f559b
https://doi.org/10.11138/fneur/2015.30.1.067
https://doi.org/10.11138/fneur/2015.30.1.067
Publikováno v:
Clinical neuropharmacology. 37(5)
Etoricoxib is a newer cyclooxygenase (COX)-2 inhibitor anti-inflammatory drug with a favorable safety profile. However, several randomized trials have provided evidence of an increased risk for acute myocardial infarction associated with the use of C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4ded95fda5ea7239268f8bf78a394f0
https://pubmed.ncbi.nlm.nih.gov/25229174
https://pubmed.ncbi.nlm.nih.gov/25229174